Skip to main content

Advertisement

Table 6 Anthropometric measurements (ITT) at different control times (T1 baseline and, T5, T9, T13) in groups treated with PG and O

From: Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity

Variable Group T1 T1 - T5 T1 - T9 T1 - T13
Weight (kg) polyglucosamine 100.6 ± 13.22 3.36 ± 2.66 4.98 ± 2.90# 6.24 ± 3.46*
orlistat 98.2 ± 11.47 2.73 ± 1.48 3.32 ± 1.77 4.63 ± 2.36
BMI (kg/m2) polyglucosamine 34.6 ± 3.70 1.13 ± 0.88 1.71 ± 0.99* 2.15 ± 1.21
orlistat 34.8 ± 4.73 0.97 ± 0.54 1.20 ± 0.67 1.66 ± 0.90
WC (cm) polyglucosamine 112.4 ± 10.95 3.22 ± 3.29 5.06 ± 4.56 7.34 ± 4.83
orlistat 110.0 ± 10.38 2.53 ± 2.65 5.12 ± 2.60 5.91 ± 3.54
  1. #p <0.01, *p < 0.05